Annual CFF:
$90.31M+$74.53M(+472.08%)Summary
- As of today, NVCR annual cash from financing is $90.31 million, with the most recent change of +$74.53 million (+472.08%) on December 31, 2024.
- During the last 3 years, NVCR annual cash from financing has risen by +$64.61 million (+251.39%).
- NVCR annual cash from financing is now -79.48% below its all-time high of $440.21 million, reached on December 31, 2020.
Performance
NVCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$100.52M+$98.13M(+4111.02%)Summary
- As of today, NVCR quarterly cash from financing is $100.52 million, with the most recent change of +$98.13 million (+4111.02%) on September 30, 2025.
- Over the past year, NVCR quarterly cash from financing has increased by +$100.42 million (+100417.00%).
- NVCR quarterly cash from financing is now -82.39% below its all-time high of $570.85 million, reached on December 31, 2020.
Performance
NVCR Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$110.84M+$100.42M(+963.79%)Summary
- As of today, NVCR TTM cash from financing is $110.84 million, with the most recent change of +$100.42 million (+963.79%) on September 30, 2025.
- Over the past year, NVCR TTM cash from financing has increased by +$21.30 million (+23.78%).
- NVCR TTM cash from financing is now -81.31% below its all-time high of $592.90 million, reached on September 30, 2021.
Performance
NVCR TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +472.1% | +10000.0% | +23.8% |
| 3Y3 Years | +251.4% | +2291.0% | +604.5% |
| 5Y5 Years | +46.4% | +171.6% | +190.8% |
NVCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +483.0% | at high | >+9999.0% | at high | +963.8% |
| 5Y | 5-Year | -79.5% | +483.0% | -82.4% | +171.6% | -81.3% | +190.8% |
| All-Time | All-Time | -79.5% | +4110.5% | -82.4% | +171.6% | -81.3% | +190.8% |
NVCR Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $100.52M(+4111.0%) | $110.84M(+963.8%) |
| Jun 2025 | - | $2.39M(-54.5%) | $10.42M(-89.1%) |
| Mar 2025 | - | $5.25M(+95.4%) | $95.35M(+5.6%) |
| Dec 2024 | $90.31M(+472.1%) | $2.69M(+2585.0%) | $90.31M(+0.9%) |
| Sep 2024 | - | $100.00K(-99.9%) | $89.54M(-1.2%) |
| Jun 2024 | - | $87.32M(>+9900.0%) | $90.61M(+739.3%) |
| Mar 2024 | - | $213.00K(-88.8%) | $10.80M(-31.6%) |
| Dec 2023 | $15.79M(+1.9%) | $1.91M(+63.1%) | $15.79M(-8.7%) |
| Sep 2023 | - | $1.17M(-84.4%) | $17.29M(-14.9%) |
| Jun 2023 | - | $7.50M(+44.2%) | $20.32M(+15.8%) |
| Mar 2023 | - | $5.20M(+52.6%) | $17.55M(+13.3%) |
| Dec 2022 | $15.49M(-39.7%) | $3.41M(-18.9%) | $15.49M(-1.5%) |
| Sep 2022 | - | $4.20M(-11.2%) | $15.73M(+8.0%) |
| Jun 2022 | - | $4.74M(+50.8%) | $14.56M(-30.3%) |
| Mar 2022 | - | $3.14M(-14.0%) | $20.89M(-18.7%) |
| Dec 2021 | $25.70M(-94.2%) | $3.65M(+20.3%) | $25.70M(-95.7%) |
| Sep 2021 | - | $3.04M(-72.5%) | $592.90M(+31.9%) |
| Jun 2021 | - | $11.06M(+39.0%) | $449.38M(+1.3%) |
| Mar 2021 | - | $7.96M(-98.6%) | $443.66M(+0.8%) |
| Dec 2020 | $440.21M(+613.7%) | $570.85M(+506.3%) | $440.21M(+460.7%) |
| Sep 2020 | - | -$140.49M(-2728.5%) | -$122.06M(-460.0%) |
| Jun 2020 | - | $5.34M(+18.7%) | $33.90M(-31.1%) |
| Mar 2020 | - | $4.50M(-47.6%) | $49.21M(-20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $61.68M(-11.1%) | $8.59M(-44.5%) | $61.68M(+10.8%) |
| Sep 2019 | - | $15.47M(-25.1%) | $55.66M(+26.2%) |
| Jun 2019 | - | $20.66M(+21.7%) | $44.09M(+27.3%) |
| Mar 2019 | - | $16.97M(+561.6%) | $34.63M(-50.1%) |
| Dec 2018 | $69.37M(+1242.3%) | $2.56M(-34.3%) | $69.37M(+1.8%) |
| Sep 2018 | - | $3.90M(-65.1%) | $68.13M(+3.3%) |
| Jun 2018 | - | $11.19M(-78.4%) | $65.94M(+16.1%) |
| Mar 2018 | - | $51.71M(+3791.2%) | $56.82M(+999.5%) |
| Dec 2017 | $5.17M(-93.1%) | $1.33M(-22.4%) | $5.17M(+0.0%) |
| Sep 2017 | - | $1.71M(-17.1%) | $5.17M(-93.2%) |
| Jun 2017 | - | $2.07M(+3403.4%) | $76.31M(+1.6%) |
| Mar 2017 | - | $59.00K(-95.6%) | $75.14M(+0.0%) |
| Dec 2016 | $75.12M(-72.9%) | $1.33M(-98.2%) | $75.12M(-68.0%) |
| Sep 2016 | - | $72.85M(+7976.8%) | $235.05M(+46.2%) |
| Jun 2016 | - | $902.00K(+2100.0%) | $160.76M(-36.5%) |
| Mar 2016 | - | $41.00K(-100.0%) | $253.24M(-8.6%) |
| Dec 2015 | $276.99M(>+9900.0%) | $161.26M(>+9900.0%) | $276.99M(+139.3%) |
| Sep 2015 | - | -$1.44M(-101.5%) | $115.73M(-1.2%) |
| Jun 2015 | - | $93.39M(+292.6%) | $117.17M(+393.1%) |
| Mar 2015 | - | $23.79M(>+9900.0%) | $23.77M(>+9900.0%) |
| Dec 2014 | $2.15M(-98.8%) | - | - |
| Jun 2014 | - | -$23.00K(-148.9%) | $24.00K(-48.9%) |
| Mar 2014 | - | $47.00K | $47.00K |
| Dec 2013 | $183.32M | - | - |
FAQ
- What is NovoCure Limited annual cash from financing?
- What is the all-time high annual cash from financing for NovoCure Limited?
- What is NovoCure Limited annual cash from financing year-on-year change?
- What is NovoCure Limited quarterly cash from financing?
- What is the all-time high quarterly cash from financing for NovoCure Limited?
- What is NovoCure Limited quarterly cash from financing year-on-year change?
- What is NovoCure Limited TTM cash from financing?
- What is the all-time high TTM cash from financing for NovoCure Limited?
- What is NovoCure Limited TTM cash from financing year-on-year change?
What is NovoCure Limited annual cash from financing?
The current annual cash from financing of NVCR is $90.31M
What is the all-time high annual cash from financing for NovoCure Limited?
NovoCure Limited all-time high annual cash from financing is $440.21M
What is NovoCure Limited annual cash from financing year-on-year change?
Over the past year, NVCR annual cash from financing has changed by +$74.53M (+472.08%)
What is NovoCure Limited quarterly cash from financing?
The current quarterly cash from financing of NVCR is $100.52M
What is the all-time high quarterly cash from financing for NovoCure Limited?
NovoCure Limited all-time high quarterly cash from financing is $570.85M
What is NovoCure Limited quarterly cash from financing year-on-year change?
Over the past year, NVCR quarterly cash from financing has changed by +$100.42M (+100417.00%)
What is NovoCure Limited TTM cash from financing?
The current TTM cash from financing of NVCR is $110.84M
What is the all-time high TTM cash from financing for NovoCure Limited?
NovoCure Limited all-time high TTM cash from financing is $592.90M
What is NovoCure Limited TTM cash from financing year-on-year change?
Over the past year, NVCR TTM cash from financing has changed by +$21.30M (+23.78%)